Xylem Inc. (NYSE:XYL) Holdings Lifted by BI Asset Management Fondsmaeglerselskab A S

BI Asset Management Fondsmaeglerselskab A S boosted its position in shares of Xylem Inc. (NYSE:XYL) by 36.1% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 37,457 shares of the industrial products company’s stock after buying an additional 9,928 shares during the quarter. BI Asset Management Fondsmaeglerselskab A S’s holdings in Xylem were worth $4,841,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Kornitzer Capital Management Inc. KS boosted its stake in Xylem by 9.0% during the fourth quarter. Kornitzer Capital Management Inc. KS now owns 109,882 shares of the industrial products company’s stock valued at $12,566,000 after buying an additional 9,114 shares in the last quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main lifted its holdings in shares of Xylem by 1,503.7% during the fourth quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 1,649,926 shares of the industrial products company’s stock valued at $188,685,000 after purchasing an additional 1,547,043 shares during the last quarter. International Assets Investment Management LLC lifted its holdings in shares of Xylem by 10,296.7% during the fourth quarter. International Assets Investment Management LLC now owns 63,004 shares of the industrial products company’s stock valued at $7,205,000 after purchasing an additional 62,398 shares during the last quarter. Vanguard Group Inc. lifted its holdings in shares of Xylem by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 28,048,996 shares of the industrial products company’s stock valued at $3,207,683,000 after purchasing an additional 187,847 shares during the last quarter. Finally, Evoke Wealth LLC purchased a new stake in shares of Xylem during the fourth quarter valued at $680,000. Institutional investors own 87.96% of the company’s stock.

Xylem Stock Up 0.5 %

Shares of NYSE XYL traded up $0.65 during mid-day trading on Wednesday, reaching $134.24. 124,564 shares of the company traded hands, compared to its average volume of 1,206,007. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.22 and a current ratio of 1.67. The stock has a market cap of $32.55 billion, a PE ratio of 47.53, a price-to-earnings-growth ratio of 2.37 and a beta of 1.04. The company’s fifty day moving average is $139.02 and its two-hundred day moving average is $128.21. Xylem Inc. has a fifty-two week low of $87.59 and a fifty-two week high of $146.08.

Xylem (NYSE:XYL) last issued its quarterly earnings data on Thursday, May 2nd. The industrial products company reported $0.90 EPS for the quarter, beating analysts’ consensus estimates of $0.84 by $0.06. The business had revenue of $2.03 billion for the quarter, compared to analyst estimates of $2 billion. Xylem had a return on equity of 8.95% and a net margin of 8.34%. The firm’s revenue for the quarter was up 40.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.72 EPS. On average, analysts expect that Xylem Inc. will post 4.24 earnings per share for the current year.

Xylem Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 27th. Stockholders of record on Thursday, May 30th were issued a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.07%. The ex-dividend date was Thursday, May 30th. Xylem’s dividend payout ratio is 51.25%.

Insider Activity

In other Xylem news, CAO Geri-Michelle Mcshane sold 2,278 shares of the firm’s stock in a transaction that occurred on Monday, June 10th. The stock was sold at an average price of $138.63, for a total value of $315,799.14. Following the sale, the chief accounting officer now owns 3,536 shares of the company’s stock, valued at approximately $490,195.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other Xylem news, CAO Geri-Michelle Mcshane sold 2,278 shares of the firm’s stock in a transaction that occurred on Monday, June 10th. The stock was sold at an average price of $138.63, for a total value of $315,799.14. Following the sale, the chief accounting officer now owns 3,536 shares of the company’s stock, valued at approximately $490,195.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Rodney Aulick sold 21,800 shares of the firm’s stock in a transaction that occurred on Wednesday, June 5th. The shares were sold at an average price of $139.01, for a total value of $3,030,418.00. Following the completion of the sale, the senior vice president now directly owns 76,287 shares in the company, valued at approximately $10,604,655.87. The disclosure for this sale can be found here. 0.27% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several brokerages have recently commented on XYL. TD Cowen upped their target price on Xylem from $135.00 to $138.00 and gave the company a “buy” rating in a report on Thursday, June 6th. Royal Bank of Canada increased their price objective on Xylem from $157.00 to $162.00 and gave the stock an “outperform” rating in a research note on Friday, May 3rd. Citigroup increased their price objective on Xylem from $126.00 to $139.00 and gave the stock a “neutral” rating in a research note on Monday, April 8th. Argus increased their price objective on Xylem from $146.00 to $165.00 and gave the stock a “buy” rating in a research note on Wednesday, May 29th. Finally, Oppenheimer increased their price objective on Xylem from $147.00 to $152.00 and gave the stock an “outperform” rating in a research note on Friday, May 31st. Five investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. According to MarketBeat.com, Xylem presently has a consensus rating of “Moderate Buy” and a consensus target price of $142.92.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.